Analysis of the antiviral drugs acyclovir and valacyclovir-hydrochloride in tsetse flies (Glossina pallidipes) using LC-MSMS

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 878, Issue 26, 2010, Pages 2384-2390

  Sasanya, J J ^a   Abd Alla, A M M ^a   Parker, A G ^a   Cannavan, A ^a  

^a INTERNATIONAL ATOMIC ENERGY AGENCY   (Austria)

Author keywords

Acyclovir; LC MSMS; MRM; Sterile insect technique (SIT); Tsetse; Valacyclovir

Indexed keywords

ACYCLOVIR; LC-MSMS; MRM; STERILE INSECT TECHNIQUES; TSETSE; VALACYCLOVIR;

ACETONITRILE; FORMIC ACID; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METHANOL; ORGANIC ACIDS;

VIRUSES;

ACICLOVIR; VALACICLOVIR;

ANIMAL TISSUE; ARTICLE; DRUG DETERMINATION; DRUG TISSUE LEVEL; LIQUID CHROMATOGRAPHY; NONHUMAN; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; TSETSE FLY; VALIDATION STUDY;

ACYCLOVIR; ANIMAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; ANIMALS; ANTIVIRAL AGENTS; CHROMATOGRAPHY, LIQUID; LINEAR MODELS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TSETSE FLIES; VALINE;

GLOSSINA (GENUS); GLOSSINA PALLIDIPES; HEXAPODA;

EID: 77956266388     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2010.07.008     Document Type: Article

References (16)

1. WHO WHO Program to Eliminate sleeping Sickness. Building a Global Alliance 2002, World Health Organization.
2. WHO, Human African Trypanosomiasis, 2009, accessed 9/12/2009. http://www.who.int/trypanosomiasis_african/en/index.htm.
3. Vreysen M.J. Med. Trop. (Mars) 2001, 61:397.
4. Vreysen M.J., Saleh K.M., Ali M.Y., Abdulla A.M., Zhu Z.R., Juma K.G., Dyck V.A., Msangi A.R., Mkonyi P.A., Feldmann H.U. J. Econ. Entomol. 2000, 93:123.
5. Sang R.C., Jura W.G., Otieno L.H., Mwangi R.W., Ogaja P. Curr. Microbiol. 1999, 38:349.
6. Marshall W.F., Virk A., Orenstein R., Wilson J.W., Estes L.L. Mayo Clinic Internal Medicine Concise Textbook 2007, Informahealthcare, London, p. 541. T.M. Habermann, A.K. Ghosh (Eds.).
7. Bras A.P., Sitar D.S., Aoki F.Y. Can. J. Clin. Pharmacol. 2001, 8:207.
8. Abd-Alla A.M., Cousserans F., Parker A.G., Jehle J.A., Parker N.J., Vlak J.M., Robinson A.S., Bergoin M. J. Virol. 2008, 82:4595.
9. Granero G.E., Amidon G.L. Int. J. Pharm. 2006, 317:14.
10. Soul-Lawton J., Seaber E., On N., Wootton R., Rolan P., Posner J. Antimicrob. Agents. Chemother. 1995, 39:2759.
11. Patil G.D., Yeole P.G., Wadher P.M.S.J. Int. J. ChemTech. Res. 2009, 1:16.
12. Yadav M., Upadhyay V., Singhal P., Goswami S., Shrivastav P.S. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2009, 877:680.
13. Kasiari M., Gikas E., Georgakakou S., Kazanis M., Panderi I. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2008, 864:78.
14. Liu R., Ye Y., Qiang L., Liao X., Zhao Y. Life Sci. J. 2008, 5:37.
15. US, FDA, Guidance for Industry, Bioanalytical Method Development, Center for Drug Evaluation and Research, Center for Veterinary Medicine, 2001,, accessed April 12 2010. http://www.fda.gov/downloads/Drugs/GuidanceComplianceregulatoryInformation/Guidances/UCM070107.pdf.
16. Jadhav A.S., Pathare D.B., Shingare M.S. J. Pharm. Biomed. Anal. 2007, 43:1568.